In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
July 24th, 2004 | 14 | Yes |
1H-Purine-2,6-dione, 3,7-dihydro-3-propyl-
1H-Purine-2,6-dione,3,9-dihydro-3-propyl-
3,7-Dihydro-3-propyl-1H-purine-2,6-dione
3-N-Propylxanthine;3-Propylxanthine;Enprofilina [INN-Spanish];Enprofyllinum [INN-Latin]
3-Propyl-1H-purine-2,6(3H,7H)-dione
3-Propyl-1H-purine-2,6(3H,9H)-dione
3-propyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione
3-propyl-3,7-dihydro-1H-purine-2,6-dione
3-Propyl-3,7-dihydro-purine-2,6-dione
41078-02-8; D04006; Enprofylline (USAN/INN)
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | -0.14 | 2.78 | -10.92 | 2 | 6 | 0 | 84 | 194.194 | 2 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
MP | 288 - 290 | Enamine Building Blocks |
MP | 288...290 | Enamine Building Blocks |
ALOGPS_SOLUBILITY | 5.68e+00 g/l | DrugBank-approved |
purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AA2BR-1-E | Adenosine A2b Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6400 | 0.52 | Binding ≤ 10μM |
AA2AR-1-E | Adenosine A2a Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7200 | 0.51 | Functional ≤ 10μM |
Z50512-5-O | Cavia Porcellus (cluster #5 Of 7), Other | Other | 7200 | 0.51 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AA2BR_HUMAN | P29275 | Adenosine A2b Receptor, Human | 4730 | 0.53 | Binding ≤ 10μM |
AA2AR_HUMAN | P29274 | Adenosine A2a Receptor, Human | 7200 | 0.51 | Functional ≤ 10μM |
Z50512 | Z50512 | Cavia Porcellus | 7200 | 0.51 | Functional ≤ 10μM |
Description | Species |
---|---|
Adenosine P1 receptors | |
G alpha (s) signalling events | |
NGF-independant TRKA activation |